Navigation Links
Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
Date:11/2/2009

COPENHAGEN, November 2 /PRNewswire/ -- Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.

The payment was triggered following identification of several candidate molecules that conformed to the prespecified criteria established under the terms of the original agreement. These include several accepted drug-like characteristics and nanomolar potency.

In its collaboration with Merck, Nuevolution is applying its proprietary Chemetics(R) technology to identify novel small molecule leads against drug targets of interest to Merck. Nuevolution has so far screened more than one billion small molecules against the first of the targets selected under the collaboration. The candidate molecules so far identified have been shown to disrupt an undisclosed, therapeutically relevant, protein-protein interaction in vitro.

"We are excited about the results that have been obtained thus far in the collaboration with Merck. Considering the complexity of the target, we believe that the results demonstrate the value of having access to hundreds of millions to billions of small molecules for screening," said Alex Gouliaev, CEO of Nuevolution A/S. "It is a great pleasure working with Merck's first class team of scientists, and we are looking forward to a continued fruitful outcome of the collaboration."

Merck and Nuevolution entered into a collaboration in 2008. In April 2009, Nuevolution announced an expansion to the second phase of the collaboration.

About Nuevolution

Nuevolution is a leading small molecule lead discovery company founded in 2001 and based in Copenhagen, Denmark. The company has developed Chemetics(R), a unique, patent protected hybrid of proven wet chemistry and molecular biology which represents the ultimate fragment based drug discovery technology. Chemetics(R)
'/>"/>

SOURCE Nuevolution A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015 CytRx Corporation ... development company specializing in oncology, today announced that ... Executive Officer, and David Haen , Vice ... present a corporate overview at two significant investment ... and healthcare industries: the FBR & Co. Second ...
(Date:9/1/2015)... 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... development and sale of broadly enabling, pressure cycling ... life sciences industry, today announced the publication of ... PCT Platform could play a significant role in ... is based on PCT,s unique ability to help ...
(Date:9/1/2015)... BerGenBio AS ("BerGenBio" or the ... has appointed Hilde Furberg and Dr ... of Directors, effective immediately. Hilde Furberg ... and biotech and is currently Senior Vice President Rare ... role was Vice President and General Manager of Nordic ...
Breaking Medicine Technology:CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5BerGenBio Appoints Non-Executive Directors 2
(Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic to benefit the ... Green Valley Country Club in Lafayette Hill, PA. Over the past 26 years, the ... for programs and services designed to support patients and their families during their time ...
(Date:9/1/2015)... ... 01, 2015 , ... Discovia, a leading global provider of ... has hired Scott Sanderson, an experienced business development professional and former NFL offensive ... for establishing and managing new client relationships in the Southeast U.S. He ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Zecurion, a leading ... , its groundbreaking new version of endpoint DLP developed specifically for Mac OS. , ... which more than 100 IT and information security professionals had participated. The beta test ...
(Date:9/1/2015)... ... 01, 2015 , ... Two of Washington D.C.’s most respected chefs are using ... , Recently named “the next big thing” in the culinary world by Elle ... whole story behind food and reclaiming culinary traditions on the brink of extinction. According ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed Szczesny ... October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, and ...
Breaking Medicine News(10 mins):Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2
... now breathe easy. Literally. A new vaccine called grass pollen ... quality of life and has also reduced medication requirements in ... reported in the latest issue of the Journal of Allergy ... Imperial College School of Medicine at the National Heart and ...
... the TAT vaccine has been developed in Italy as the ... importantly it has had a 71% success rate when tested ... and this may be the brightest hope for mankind against ... of Virology at Italy’s National Health Institute and Dr.Robert Gallo, ...
... Researchers developing a vaccine against Alzheimer’s disease have shown ... losing their memory. The results boost hopes that such ... ,The vaccines reduces the build-up of protein deposits ... diseases. The pharmaceutical company Elan, based in Dublin, Ireland, ...
... when the women were 16 years old and the men ... California University Researchers. ,It appears that the sexual abuse ... cancer, arthritis and thyroid diseases. It varied by gender, where ... of thyroid disease occur in men. ,There is ...
... In a path breaking idea researchers at the just concluded ... collaborative effort with agricultural scientists to combat anemia with iron ... under 3 years of age are anemic in India. While ... using it in turn to fight anemia in people is ...
... In an exciting development, in the field of criminology, a ... of America. This is called “brain fingerprinting”. This invention is ... date and is said to detect even smooth criminals who ... ease. The new method employs brain waves, which are useful ...
Cached Medicine News:
... for patients and health consumers from the ... featured in MedMaster includes why the medication ... potential side effects and warning signs of ... instructions, information on what to do if ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
... Injectable Drugs is a dynamic new ... and easy to check on the ... the selected drugs, clear compatibility and ... can quickly take clinical action based ...
... of current natural product information ... with A to Z Drug ... checking. Includes free updates for ... ideal drug reference for physicians, ...
Medicine Products: